Streetbeat News

Products Services

CMPS

The American Medical Association (AMA) has published details on the Current Procedural Terminology (CPT) III codes for psychedelic-assisted therapies. These codes, forwarded by MAPS Public Benefit Corporation and COMPASS Pathways (NASDAQ:CMPS), are temporary and assigned to emerging technologies and services to facilitate reimbursement and access to psychedelic therapies in the U.S., if federally approved. The codes are expected to become effective on January 1, 2024, and will provide healthcare professionals a means to seek coverage and reimbursement for delivering psychedelic medication therapy.

Portfolio Pulse from Lara Goldstein

July 06, 2023 | 5:47 pm

PLTR

Palantir Technologies Inc's (NYSE:PLTR) shares are trading lower alongside several tech companies due to concerns about further rate hikes following Thursday's jobs data. The ADP National Employment Report showed that U.S. private employers added 497,000 jobs in June, raising the likelihood of more interest rate hikes from the Federal Reserve. Despite the pullback, Palantir shares are up more than 85% over the last three months, driven by better-than-expected quarterly results and strong demand for its new AI platform.

Portfolio Pulse from Adam Eckert

July 06, 2023 | 5:42 pm

LTBR

SMR

Lightbridge Corporation (NASDAQ:LTBR) announced that Texas A&M University has been awarded approximately $1M by the U.S. Department of Energy to study the performance of Lightbridge Fuel in a small modular reactor (SMR) designed by NuScale Power (NYSE:SMR). The study will be conducted over three years and will be funded entirely by the DOE. Structural Integrity Associates will perform the thermal evaluation of Lightbridge Fuel in the SMR using its PEGASUS simulation software.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 5:32 pm

AMST

Amesite Inc. has filed a new patent application titled 'Generative Artificial Intelligence Learning Method And System For An On-line Course'. The patent application is available for public viewing on the United States Patent and Trademark Office website.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 5:02 pm

CRVS

Corvus Pharmaceuticals (NASDAQ:CRVS) has published preclinical data on its ITK inhibitor product candidate, soquelitinib, demonstrating its potential to enhance anti-tumor immune response to hematologic and solid tumors. The data suggests that ITK inhibition could be a novel approach to cancer immunotherapy. Soquelitinib is currently being studied in a Phase 1/1b clinical trial for patients with relapsed T cell lymphoma (TCL). Corvus plans to meet with the FDA in Q3 2023 to discuss a Phase 3 registration clinical trial in patients with relapsed TCL.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 5:02 pm

PCRFY

STLA

TM

TSLA

WKSP

Stellantis N.V. (NYSE:STLA) unveiled its new EV platform, while Toyota Motor (NYSE:TM) promised to halve battery cost and size. Worksport Ltd (NASDAQ:WKSP) announced a strategic partnership to secure federal grants. Panasonic Holdings Corporation (OTC:PCRFY), a Tesla Inc (NASDAQ:TSLA) supplier, plans to build four more battery plants.

Portfolio Pulse from Upwallstreet

July 06, 2023 | 4:51 pm

AAPL

Apple Inc. is reportedly reducing its production forecasts for the Vision Pro headset due to production delays. Despite this, Jim Cramer believes the device will be a game changer and advises investors not to worry about the production cut. He suggests that the headset will provide unique experiences, such as feeling like being in the front row of a concert, which justifies its high price. Apple shares were down 0.35% at the time of the report.

Portfolio Pulse from Adam Eckert

July 06, 2023 | 4:45 pm

AMD

TSM

AMD's CEO Lisa Su is planning a visit to Taiwan in mid-July with a priority to secure TSMC's available CoWoS packaging capacity, as per industry sources.

Portfolio Pulse from Happy Mohamed

July 06, 2023 | 4:31 pm

GOOG

NTDOY

SPY

Since the release of Pokemon Go in 2016, an investment in Nintendo Co (OTC:NTDOY) would have yielded a return of 208.9%. The game, developed by Niantic, a company spun out of Alphabet Inc (NASDAQ:GOOG)(NASDAQ:GOOGL), generated billions of dollars in revenue annually at its peak. Nintendo, a 33% owner of The Pokemon Company and a partial owner of Niantic, was a popular stock for investors during the game's peak popularity. The same investment in the SPDR S&P 500 ETF (NYSE:SPY) would have returned 108.6%.

Portfolio Pulse from Chris Katje

July 06, 2023 | 4:22 pm

VXRT

Vaxart Inc has announced positive preliminary data from the Phase 2 trial of its oral pill bivalent norovirus vaccine candidate. The results showed strong serum immune responses across all doses and a favorable safety profile. The company expects to have additional data in the second half of 2023, which will inform dosage amounts for a Phase 2b study. If successful, this could lead to an End-of-Phase 2 meeting with the FDA in 2024. VXRT shares are currently down 3.11%.

Portfolio Pulse from Vandana Singh

July 06, 2023 | 4:19 pm